Galanin enhances systemic glucose metabolism through enteric Nitric Oxide Synthase-expressed neurons

OBJECTIVE: Decreasing duodenal contraction is now considered as a major focus for the treatment of type 2 diabetes. Therefore, identifying bioactive molecules able to target the enteric nervous system, which controls the motility of intestinal smooth muscle cells, represents a new therapeutic avenue...

Descripción completa

Detalles Bibliográficos
Autores principales: Abot, Anne, Lucas, Alexandre, Bautzova, Tereza, Bessac, Arnaud, Fournel, Audren, Le-Gonidec, Sophie, Valet, Philippe, Moro, Cédric, Cani, Patrice D., Knauf, Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985240/
https://www.ncbi.nlm.nih.gov/pubmed/29428595
http://dx.doi.org/10.1016/j.molmet.2018.01.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985240/
https://www.ncbi.nlm.nih.gov/pubmed/29428595
http://dx.doi.org/10.1016/j.molmet.2018.01.020

Ejemplares similares